The NucliSENS EasyQ KPC assay (bioMérieux SA, Marcy l'Etoile, France) was compared with a routinely used phenotypic method for detection of Enterobacteriaceae producing Klebsiella pneumoniae carbapenemase (KPC)-type carbapenemases, using 806 stool samples and rectal swabs. Compared with the phenotypic method, the EasyQ KPC assay had a sensitivity and specificity of 93.3% and 99.0%, respectively...

BACKGROUND Rapid detection of carbapenemase-producing gram-negative bacilli (GNB) is required for optimal treatment of infected patients. We developed and assessed a new disk carbapenemase test (DCT). METHODS Paper disks containing 0.3 mg of imipenem and bromothymol blue indicator were developed, and the performance of the DCT were evaluated by using 742 strains of GNB with or without carbape...

OBJECTIVES To assess the performance of three commercial molecular assays for detecting major families of carbapenemases in pure bacterial isolates. METHODS A panel of 450 isolates with previously defined carbapenem resistance mechanisms was tested using the Check-Direct CPE kit, the eazyplex(®) SuperBug complete A kit and the Xpert(®) Carba-R kit. Isolates included 438 Enterobacteriaceae and...

Carbapenems, such as imipenem and meropenem, are most often used to treat infections caused by enterobacteria that produce extended-spectrum beta-lactamases, and the emergence of enzymes capable of inactivating carbapenems would therefore limit the options for treatment. Carbapenem resistance in Enterobacteriaceae is rare, but class A beta-lactamases with activity against the carbapenems are be...

In recent years, Enterobacteriaceae isolates have increased their potential to become highly drug resistant by acquiring resistance to carbapenems, primarily due to the production of acquired carbapenemases. The carbapenemases detected in Enterobacteriaceae are largely of the KPC, VIM, NDM, IMP and OXA-48 types. Although the epidemiological origin and geographic distribution of carbapenemases a...

INTRODUCTION: Creation of protocols for effective empiric antimicrobial therapy is impossible without the analysis current antibiotic susceptibility data. OBJECTIVE: Analysis changes in etiological significance leading pathogens bacteremia ICU (intensive care unit) period from 2003 to 2021, and their sensitivity antibiotics; study types carbapenemases most relevant — Klebsiella pneumoniae Acine...

BACKGROUND During the last decade, the prevalence of carbapenem-resistant Enterobacteriaceae in human patients has increased. Carbapenemase-producing bacteria are usually multidrug resistant. Therefore, early recognition of carbapenemase producers is critical to prevent their spread. OBJECTIVES The objective of this study was to develop the primers for single and/or multiplex PCR amplificatio...

Sir, The worldwide emergence of carbapenemases is a major health issue leaving clinicians with few treatment options. Implementation of infection prevention and control (IPC) procedures relies on early detection of carbapenemase producers and distinction from other carbapenem resistance mechanisms. Various carbapenem hydrolysis methods allow detection of carbapenemase activity but do not differ...

Background: This study aimed to investigate the distribution pattern of carbapenemases and evaluate their solitary contribution carbapenem resistance.

Enterobacteriaceae producing class D OXA-48 and OXA-48-like carbapenemases are an increasing concern. Detection is a diagnostic challenge because (i) some isolates are carbapenem susceptible and may go unrecognized, (ii) tests that detect carbapenem hydrolysis may be insensitive due to the relatively weak hydrolytic activity of these enzymes, (iii) the enzymes are not significantly inhibited by...